- Home
- SWAG vs KZR Comparison
SWAG vs KZR Comparison
Compare SWAG & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWAG
- KZR
- Stock Information
- Founded
- SWAG 1994
- KZR 2015
- Country
- SWAG United States
- KZR United States
- Employees
- SWAG N/A
- KZR N/A
- Industry
- SWAG Advertising
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- SWAG Consumer Discretionary
- KZR Health Care
- Exchange
- SWAG Nasdaq
- KZR Nasdaq
- Market Cap
- SWAG 31.2M
- KZR 29.7M
- IPO Year
- SWAG 2021
- KZR 2018
- Fundamental
- Price
- SWAG $1.99
- KZR $6.10
- Analyst Decision
- SWAG
- KZR Hold
- Analyst Count
- SWAG 0
- KZR 4
- Target Price
- SWAG N/A
- KZR $6.00
- AVG Volume (30 Days)
- SWAG 36.3K
- KZR 468.6K
- Earning Date
- SWAG 11-12-2025
- KZR 11-07-2025
- Dividend Yield
- SWAG N/A
- KZR N/A
- EPS Growth
- SWAG N/A
- KZR N/A
- EPS
- SWAG N/A
- KZR N/A
- Revenue
- SWAG $108,405,000.00
- KZR N/A
- Revenue This Year
- SWAG N/A
- KZR N/A
- Revenue Next Year
- SWAG N/A
- KZR N/A
- P/E Ratio
- SWAG N/A
- KZR N/A
- Revenue Growth
- SWAG 38.74
- KZR N/A
- 52 Week Low
- SWAG $0.73
- KZR $3.53
- 52 Week High
- SWAG $2.04
- KZR $7.65
- Technical
- Relative Strength Index (RSI)
- SWAG 67.00
- KZR 70.93
- Support Level
- SWAG $1.86
- KZR $6.06
- Resistance Level
- SWAG $1.98
- KZR $6.29
- Average True Range (ATR)
- SWAG 0.08
- KZR 0.21
- MACD
- SWAG 0.02
- KZR -0.02
- Stochastic Oscillator
- SWAG 93.94
- KZR 61.04
About SWAG Stran & Company Inc.
Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, it offers its clients custom sourcing capabilities, which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, event assets, order and inventory management, and designing and hosting online retail pop-up shops. The company's segment consists of the Stran segment and the SLS segment. The company generates the majority of its revenue from the Stran segment.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.